
CAS 853953-65-8
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
5-(5-(6-(4-Acetylpiperazin-1-yl)-3-nitropyridin-2-yl)-2-fluorobenzylidene)thiazolidine-2,4-dione
CAS :Formule :C21H18FN5O5SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :471.46155-(5-(6-(4-Acetylpiperazin-1-Yl)-3-Nitropyridin-2-Yl)-2-Fluorobenzylidene)Thiazolidine-2,4-Dione
CAS :5-(5-(6-(4-Acetylpiperazin-1-Yl)-3-Nitropyridin-2-Yl)-2-Fluorobenzylidene)Thiazolidine-2,4-DioneDegré de pureté :98%Masse moléculaire :471.46g/molGW604714X
CAS :GW604714X (2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]-) were found to be potent inhibitors ofFormule :C21H18FN5O5SDegré de pureté :98.05%Couleur et forme :SolidMasse moléculaire :471.46GW604714X
CAS :GW604714X is a medicinal compound that belongs to the family of kinase inhibitors. It has been shown to have potent anticancer properties and can induce apoptosis in human cancer cells. GW604714X is an analog of a protein kinase inhibitor and has been found to be effective in inhibiting tumor growth. This compound has been extensively studied for its ability to target specific kinases involved in cancer cell proliferation. GW604714X has shown promising results in preclinical studies as a potential treatment for various types of cancers, including Chinese hamster ovary (CHO) cells. The compound is detectable in urine, making it a potential biomarker for monitoring treatment response.Formule :C21H18FN5O5SDegré de pureté :Min. 95%Masse moléculaire :471.5 g/mol



